Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
cg-0255 besylate for
Peripheral Arterial Disease
Shanghai CureGene Pharmaceutical Co., Ltd.
P1
CC
(43)
cg-0255 besylate for
Myocardial Infarction
Shanghai CureGene Pharmaceutical Co., Ltd.
P1
CC
(43)
cg-0255 besylate for
Stroke Disorder
Shanghai CureGene Pharmaceutical Co., Ltd.
P1
CC
(43)
cgt4255
HER2 Positive Breast Carcinoma
Cogent Biosciences, Inc.
P1
CC
(43)
Chimeric Antigen Receptor Modified T Cells Infusion
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nelson Hamerschlak
P1
CC
(43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Malignant Glioma
City of Hope Medical Center
P1
CC
(43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Grade II Glioma
City of Hope Medical Center
P1
CC
(43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Grade III Glioma
City of Hope Medical Center
P1
CC
(43)
Chm-1101 Car-T Cells
Brain Glioblastoma
Chimeric Therapeutics
P1
CC
(43)
Cholestyramine
Pancreatic Adenocarcinoma
City of Hope Medical Center
P1
CC
(43)
Cholestyramine
Malignant Pancreatic Neoplasm
City of Hope Medical Center
P1
CC
(43)
Cholestyramine
Pancreatic Ductal Adenocarcinoma
City of Hope Medical Center
P1
CC
(43)
cht101
Cervical Cancer
Zhejiang University
P1
CC
(43)
cht101
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and Hospital
P1
CC
(43)
cht101
Metastatic Neoplasm
Zhejiang University
P1
CC
(43)
cht101
Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and Hospital
P1
CC
(43)
cht102
Malignant Pancreatic Neoplasm
Tianjin Medical University Cancer Institute and Hospital
P1
CC
(43)
Cid-078 Monotherapy
Refractory Malignant Neoplasm
Circle Pharma
P1
CC
(43)
Cilansetron
Cancer
EMD Serono Research & Development Institute, Inc.
P1
CC
(43)
Ciml-Nk Cells
Juvenile Myelomonocytic Leukemia
Dana-Farber Cancer Institute
P1
CC
(43)
Ciml-Nk Cell Therapy
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Cirtociclib
Carcinosarcoma
Blueprint Medicines Corporation
P1
CC
(43)
Cirtuvivint
Ovarian Endometrioid Adenocarcinoma
University of Colorado, Denver
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Bile Duct Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cis-Diamminedichloroplatinum Ii
Carcinoma Of Esophagus
National Cancer Institute (NCI)
P1
CC
(43)
Showing 1626 to 1650 of 9,928 assets
Previous
Page 66 of 398
Next
